Gael Forterre - 13 Oct 2022 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Gael Forterre
Issuer symbol
VNRX
Transactions as of
13 Oct 2022
Net transactions value
$0
Form type
4
Filing time
14 Oct 2022, 16:04:16 UTC
Previous filing
05 Aug 2022
Next filing
13 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +8,050 +12% $0.000000 73,425 13 Oct 2022 Direct F1
holding VNRX Common Stock 5,000 13 Oct 2022 By Spouse
holding VNRX Common Stock 32,500 13 Oct 2022 By Armori Capital Management, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 4, 2022, the reporting person was awarded 46,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 8,050 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 2,684 units, 2,683 units, and 2,683 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F2 These shares of common stock are managed by Armori Capital Management, LLC ("Armori Capital"). Mr. Forterre is the managing director and sole shareholder of Armori Capital and has voting and dispositive control over the shares held by Armori Capital. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.